DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $620,000 | -45.5% | 46,098 | -21.3% | 0.04% | -30.8% |
Q3 2018 | $1,137,000 | +18.4% | 58,575 | +55.9% | 0.06% | +6.6% |
Q2 2018 | $960,000 | -21.2% | 37,571 | -37.9% | 0.06% | -25.6% |
Q1 2018 | $1,219,000 | -29.1% | 60,503 | -29.4% | 0.08% | -24.1% |
Q4 2017 | $1,719,000 | +19.5% | 85,650 | +23.3% | 0.11% | +21.3% |
Q3 2017 | $1,438,000 | +42.5% | 69,441 | +1.9% | 0.09% | +30.9% |
Q2 2017 | $1,009,000 | +16.6% | 68,154 | +25.6% | 0.07% | +15.3% |
Q1 2017 | $865,000 | +33.5% | 54,246 | +5.5% | 0.06% | +22.9% |
Q4 2016 | $648,000 | -93.3% | 51,408 | -85.0% | 0.05% | -93.3% |
Q3 2016 | $9,601,000 | -20.0% | 342,768 | -0.0% | 0.72% | -24.3% |
Q2 2016 | $12,000,000 | +125.5% | 342,839 | +76.6% | 0.95% | +96.3% |
Q1 2016 | $5,321,000 | -17.6% | 194,187 | +2.9% | 0.48% | -17.5% |
Q4 2015 | $6,460,000 | +17.1% | 188,766 | -1.7% | 0.58% | +10.2% |
Q3 2015 | $5,518,000 | -21.3% | 192,079 | +22.7% | 0.53% | -18.1% |
Q2 2015 | $7,007,000 | – | 156,591 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |